Interactions of cytosolic sulfotransferases with xenobiotics

References

• Al-Dujaili EA, Kenyon CJ, Nicol MR, Mason JI. (2011). Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity. Mol Cell Endocrinol 336:102–109
   PubMed Web of Science ®Google Scholar
• Allmyr M, Adolfsson-Erici M, Mclachlan MS, Sandborgh-Englund G. (2006). Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 372:87–93
   PubMed Web of Science ®Google Scholar
• Allmyr M, Panagiotidis G, Sparve E, et al. (2009). Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones. Basic Clin Pharmacol Toxicol 105:339–344
   PubMed Web of Science ®Google Scholar
• Ambadapadi S, Palii SP, James MO. (2011). Celecoxib modulation of estrogen sulfonation by SULT2A1 enzyme in vitro. American Association of Pharmaceutical Scientists Annual Meeting. Washington, DC: AAPS
   Google Scholar
• Anderson RJ, Kudlacek PE, Clemens DL. (1998). Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact 109:53–67
   PubMed Web of Science ®Google Scholar
• Augustsson K, Skog K, Jagerstad M, et al. (1999). Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: A population-based study. Lancet 353:703–707
   PubMed Web of Science ®Google Scholar
• Bamforth KJ, Dalgliesh K, Coughtrie MW. (1992). Inhibition of human liver steroid sulfotransferase activities by drugs: A novel mechanism of drug toxicity? Eur J Pharmacol 228:15–21
   PubMed Web of Science ®Google Scholar
• Bamforth KJ, Jones AL, Roberts RC, Coughtrie MW. (1993). Common food additives are potent inhibitors of human liver 17 alpha-ethinyloestradiol and dopamine sulphotransferases. Biochem Pharmacol 46:1713–1720
   PubMed Web of Science ®Google Scholar
• Berger I, Guttman C, Amar D, et al. (2011). The molecular basis for the broad substrate specificity of human sulfotransferase 1A1. PLoS One 6:e26794
   PubMed Web of Science ®Google Scholar
• Calafat AM, Ye X, Wong LY, et al. (2008). Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ Health Perspect 116:303–307
   PubMed Web of Science ®Google Scholar
• Cer RZ, Mudunuri U, Stephens R, Lebeda FJ. (2009). IC50-to-Ki: A web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding. Nucleic Acids Res 37:W441–5
   PubMed Web of Science ®Google Scholar
• Charbit AR, Akerman S, Goadsby PJ. (2010). Dopamine: What's new in migraine? Curr Opin Neurol 23:275–281
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang D, Jing N, et al. (2003). Human gastrointestinal sulfotransferases: Identification and distribution. Toxicol Appl Pharmacol 187:186–197
   PubMed Web of Science ®Google Scholar
• Claustre J, Serusclat P, Peyrin L. (1983). Glucuronide and sulfate catecholamine conjugates in rat and human plasma. J Neural Transm 56:265–278
   PubMed Web of Science ®Google Scholar
• Comer KA, Falany CN. (1992). Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Mol Pharmacol 41:645–651
   PubMed Web of Science ®Google Scholar
• Cornish-Bowden A. (2004). Fundamentals of enzyme kinetics. London: Portland Press
   Google Scholar
• Coughtrie MW, Johnston LE. (2001). Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug Metab Dispos 29:522–528
   PubMed Web of Science ®Google Scholar
• Coughtrie MW, Sharp S, Maxwell K, Innes NP. (1998). Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact 109:3–27
   PubMed Web of Science ®Google Scholar
• Crofton KM. (2008). Thyroid disrupting chemicals: Mechanisms and mixtures. Int J Androl 31:209–222
   PubMedGoogle Scholar
• Cui D, Booth-Genthe CL, Carlini E, et al. (2004). Heterotropic modulation of sulfotransferase 2A1 activity by celecoxib: Product ratio switching of ethynylestradiol sulfation. Drug Metab Dispos 32:1260–1264
   PubMed Web of Science ®Google Scholar
• Dajani R, Cleasby A, Neu M, et al. (1999). X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem 274:37862–37868
   PubMed Web of Science ®Google Scholar
• Dajani R, Hood AM, Coughtrie MWH. (1998). A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol Pharmacol 54:942–948
   PubMed Web of Science ®Google Scholar
• De Santi C, Pietrabissa A, Mosca F, et al. (2002). Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. Xenobiotica 32:363–368
   PubMed Web of Science ®Google Scholar
• De Santi C, Pietrabissa A, Spisni R, et al. (2000). Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30:857–866
   PubMed Web of Science ®Google Scholar
• Den Hond E, Paulussen M, Geens T, et al. (2013). Biomarkers of human exposure to personal care products: Results from the Flemish Environment and Health Study (FLEHS 2007–2011). Sci Total Environ 463–464C:102–110
   Web of Science ®Google Scholar
• Djuric Z, Severson RK, Kato I. (2012). Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr Cancer 64:351–360
   PubMed Web of Science ®Google Scholar
• Duanmu ZB, Weckle A, Koukouritaki SB, et al. (2006). Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 316:1310–1317
   PubMed Web of Science ®Google Scholar
• Eagle K. (2012a). SULT1A inhibition and how a migraine stops. Headache 52:1321
   PubMed Web of Science ®Google Scholar
• Eagle K. (2012b). Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines. Food Chem Toxicol 50:2243–2249
   PubMed Web of Science ®Google Scholar
• Eaton EA, Walle UK, Lewis AJ, et al. (1996). Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos 24:232–237
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Aneman A, Friberg P, et al. (1997). Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864–3871
   PubMed Web of Science ®Google Scholar
• Ekuase EJ, Liu Y, Lehmler HJ, et al. (2011). Structure-activity relationships for hydroxylated polychlorinated biphenyls as inhibitors of the sulfation of dehydroepiandrosterone catalyzed by human hydroxysteroid sulfotransferase SULT2A1. Chem Res Toxicol 24:1720–1728
   PubMed Web of Science ®Google Scholar
• Falany CN. (1991). Molecular enzymology of human liver cytosolic sulfotransferases. Trends Pharmacol Sci 12:255–259
   PubMed Web of Science ®Google Scholar
• Falany CN. (1997). Enzymology of human cytosolic sulfotransferases. FASEB J 11:206–216
   PubMed Web of Science ®Google Scholar
• Furimsky AM, Green CE, Sharp LE, et al. (2008). Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1. Drug Metab Dispos 36:129–136
   PubMed Web of Science ®Google Scholar
• Gamage NU, Tsvetanov S, Duggleby RG, et al. (2005). The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates. J Biol Chem 280:41482–41486
   PubMed Web of Science ®Google Scholar
• Gibb C, Glover V, Sandler M. (1987). In vitro inhibition of phenolsulphotransferase by food and drink constituents. Biochem Pharmacol 36:2325–2330
   PubMed Web of Science ®Google Scholar
• Glatt H. (2002). Sulphotransferases. In: Ioannides C, ed. Enzyme Systems that Metabolise Drugs and Other Xenobiotics. Chichester: John Wiley & Sons, Ltd., 353–439
   Google Scholar
• Glatt H. (2005). Activation and inactivation of carcinogens and mutagens by human sulfotransferases. In: Pacifici GM, Coughtrie MWH, eds. Human Cytosolic Sulfotransferases. Boca Raton, Taylor and Francis
   Google Scholar
• Guvenius DM, Hassanzadeh P, Bergman A, Noren K. (2002). Metabolites of polychlorinated biphenyls in human liver and adipose tissue. Environ Toxicol Chem 21:2264–2269
   PubMed Web of Science ®Google Scholar
• Hamers T, Kamstra JH, Sonneveld E, et al. (2006). In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol Sci 92:157–173
   PubMed Web of Science ®Google Scholar
• Harris RM, Hawker RJ, Langman MJ, et al. (1998). Inhibition of phenolsulphotransferase by salicylic acid: A possible mechanism by which aspirin may reduce carcinogenesis. Gut 42:272–275
   PubMed Web of Science ®Google Scholar
• Harris RM, Kirk CJ, Waring RH. (2005). Non-genomic effects of endocrine disrupters: Inhibition of estrogen sulfotransferase by phenols and chlorinated phenols. Mol Cell Endocrinol 244:72–74
   PubMed Web of Science ®Google Scholar
• Harris RM, Waring RH. (2008). Sulfotransferase inhibition: Potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. Curr Drug Metab 9:269–275
   PubMed Web of Science ®Google Scholar
• Her C, Szumlanski C, Aksoy IA, Weinshilboum RM. (1996). Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: Immunochemical characterization of individual variation. Drug Metab Dispos 24:1328–1335
   PubMed Web of Science ®Google Scholar
• Heroux JA, Falany CN, Roth JA. (1989). Immunological characterization of human phenol sulfotransferase. Mol Pharmacol 36:29–33
   PubMed Web of Science ®Google Scholar
• Hoelzl C, Glatt H, Meinl W, et al. (2008). Consumption of Brussels sprouts protects peripheral human lymphocytes against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and oxidative DNA-damage: Results of a controlled human intervention trial. Mol Nutr Food Res 52:330–341
   PubMed Web of Science ®Google Scholar
• Huang C, Chen Y, Zhou T, Chen G. (2009). Sulfation of dietary flavonoids by human sulfotransferases. Xenobiotica 39:312–322
   PubMed Web of Science ®Google Scholar
• James MO, Li W, Summerlot DP, et al. (2010). Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta. Environ Int 36:942–949
   PubMed Web of Science ®Google Scholar
• Jones AL, Roberts RC, Colvin DW, et al. (1995). Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine. Eur J Clin Pharmacol 49:109–114
   PubMed Web of Science ®Google Scholar
• Kester MH, Bulduk S, Tibboel D, et al. (2000). Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: A novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141:1897–1900
   PubMed Web of Science ®Google Scholar
• Kester MH, Bulduk S, Van Toor H, et al. (2002). Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 87:1142–1150
   PubMed Web of Science ®Google Scholar
• King RS, Ghosh AA, Wu J. (2006). Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents. Curr Drug Metab 7:745–753
   PubMed Web of Science ®Google Scholar
• Ko K, Kurogi K, Davidson G, et al. (2012). Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases. J Biochem 152:275–283
   PubMed Web of Science ®Google Scholar
• Koal T, Schmiederer D, Pham-Tuan H, et al. (2012). Standardized LC-MS/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol 129:129–138
   PubMed Web of Science ®Google Scholar
• Littlewood JT, Glover V, Sandler M. (1985). Red wine contains a potent inhibitor of phenolsulphotransferase. Br J Clin Pharmacol 19:275–278
   PubMed Web of Science ®Google Scholar
• Liu Y, Apak TI, Lehmler HJ, et al. (2006). Hydroxylated polychlorinated biphenyls are substrates and inhibitors of human hydroxysteroid sulfotransferase SULT2A1. Chem Res Toxicol 19:1420–1425
   PubMed Web of Science ®Google Scholar
• Liu Y, Lehmler HJ, Robertson LW, Duffel MW. (2011). Physicochemical properties of hydroxylated polychlorinated biphenyls aid in predicting their interactions with rat sulfotransferase 1A1 (rSULT1A1). Chem Biol Interact 189:153–160
   PubMed Web of Science ®Google Scholar
• Liu Y, Smart JT, Song Y, et al. (2009). Structure-activity relationships for hydroxylated polychlorinated biphenyls as substrates and inhibitors of rat sulfotransferases and modification of these relationships by changes in thiol status. Drug Metab Dispos 37:1065–1072
   PubMed Web of Science ®Google Scholar
• Ma B, Shou M, Schrag ML. (2003). Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro. Drug Metab Dispos 31:1300–1305
   PubMed Web of Science ®Google Scholar
• Marchetti F, De Santi C, Vietri M, et al. (2001). Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 31:841–847
   PubMed Web of Science ®Google Scholar
• Mesia-Vela S, Kauffman FC. (2003). Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica 33:1211–1220
   PubMed Web of Science ®Google Scholar
• Miksits M, Maier-Salamon A, Aust S, et al. (2005). Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35:1101–1119
   PubMed Web of Science ®Google Scholar
• Miksits M, Wlcek K, Svoboda M, et al. (2010). Expression of sulfotransferases and sulfatases in human breast cancer: Impact on resveratrol metabolism. Cancer Lett 289:237–245
   PubMed Web of Science ®Google Scholar
• Miners JO, Lillywhite KJ, Yoovathaworn K, et al. (1990). Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver-microsomes. Biochem Pharmacol 40:595–600
   PubMed Web of Science ®Google Scholar
• Morimitsu Y, Sugihara N, Furuno K. (2004). Inhibitory effect of flavonoids on sulfo- and glucurono-conjugation of acetaminophen in rat cultured hepatocytes and liver subcellular preparations. Biol Pharm Bull 27:714–717
   PubMed Web of Science ®Google Scholar
• Nagai M, Fukamachi T, Tsujimoto M, et al. (2009). Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol Pharm Bull 32:105–109
   PubMed Web of Science ®Google Scholar
• Nagar S, Walther S, Blanchard RL. (2006). Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol Pharmacol 69:2084–2092
   PubMed Web of Science ®Google Scholar
• Nishimuta H, Ohtani H, Tsujimoto M, et al. (2007). Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos 28:491–500
   PubMed Web of Science ®Google Scholar
• Nishimuta H, Tsujimoto M, Ogura K, et al. (2005). Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3. Pharm Res 22:1406–1410
   PubMed Web of Science ®Google Scholar
• Ohkimoto K, Liu MY, Suiko M, et al. (2004). Characterization of a zebrafish estrogen-sulfating cytosolic sulfotransferase: Inhibitory effects and mechanism of action of phytoestrogens. Chem Biol Interact 147:1–7
   PubMed Web of Science ®Google Scholar
• Otake Y, Nolan AL, Walle UK, Walle T. (2000). Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J Steroid Biochem Mol Biol 73:265–270
   PubMed Web of Science ®Google Scholar
• Pasqualini JR, Chetrite GS. (2005). Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93:221–236
   PubMed Web of Science ®Google Scholar
• Rampling RP, Bonham Carter SM, Glover V, Sandler M. (1984). Platelet monoamine oxidase and phenolsulphotransferase M and P in cancer. Clin Chim Acta 139:303–312
   PubMed Web of Science ®Google Scholar
• Ratge D, Knoll E, Wisser H. (1986). Plasma free and conjugated catecholamines in clinical disorders. Life Sci 39:557–564
   PubMed Web of Science ®Google Scholar
• Rehse PH, Zhou M, Lin SX. (2002). Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate. Biochem J 364:165–171
   PubMed Web of Science ®Google Scholar
• Reith D, Medlicott NJ, Kumara De Silva R, et al. (2009). Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation. Clin Exp Pharmacol Physiol 36:35–42
   PubMed Web of Science ®Google Scholar
• Richard K, Hume R, Kaptein E, et al. (2001). Sulfation of thyroid hormone and dopamine during human development: Ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab 86:2734–2742
   PubMed Web of Science ®Google Scholar
• Riches Z, Stanley EL, Bloomer JC, Coughtrie MW. (2009). Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: The SULT “pie”. Drug Metab Dispos 37:2255–2261
   PubMed Web of Science ®Google Scholar
• Rohn KJ, Cook IT, Leyh TS, et al. (2012). Potent inhibition of human sulfotransferase 1A1 by 17alpha-ethinylestradiol: Role of 3′-phosphoadenosine 5′-phosphosulfate binding and structural rearrangements in regulating inhibition and activity. Drug Metab Dispos 40:1588–1595
   PubMed Web of Science ®Google Scholar
• Runge-Morris M, Kocarek TA, Falany CN. (2013). Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab Rev 45:15–33
   PubMed Web of Science ®Google Scholar
• Sandau CD, Ayotte P, Dewailly E, et al. (2000). Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian inuit. Environ Health Perspect 108:611–616
   PubMed Web of Science ®Google Scholar
• Sandau CD, Ayotte P, Dewailly E, et al. (2002). Pentachlorophenol and hydroxylated polychlorinated biphenyl metabolites in umbilical cord plasma of neonates from coastal populations in Quebec. Environ Health Perspect 110:411–417
   PubMed Web of Science ®Google Scholar
• Saruwatari A, Okamura S, Nakajima Y, et al. (2008). Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells. J Med Food 11:623–628
   PubMed Web of Science ®Google Scholar
• Schrag ML, Cui DH, Rushmore TH, et al. (2004). Sulfotransferase 1E1 is a low K-M isoform mediating the 3-O-sulfation of ethinyl estradiol. Drug Metab Dispos 32:1299–1303
   PubMed Web of Science ®Google Scholar
• Schuur AG, Bergman A, Brouwer A, Visser TJ. (1999). Effects of pentachlorophenol and hydroxylated polychlorinated biphenyls on thyroid hormone conjugation in a rat and a human hepatoma cell line. Toxicol in Vitro 13:417–425
   PubMed Web of Science ®Google Scholar
• Schuur AG, Legger FF, Van Meeteren ME, et al. (1998a). In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol 11:1075–1081
   PubMed Web of Science ®Google Scholar
• Schuur AG, Van Leeuwen-Bol I, Jong WM, et al. (1998b). In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: Isozyme specificity and inhibition kinetics. Toxicol Sci 45:188–194
   PubMed Web of Science ®Google Scholar
• Schwaninger AE, Meyer MR, Zapp J, Maurer HH. (2011). Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases. Toxicol Lett 202:120–128
   PubMed Web of Science ®Google Scholar
• Senggunprai L, Yoshinari K, Yamazoe Y. (2009). Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases. Biochem J 422:455–462
   PubMed Web of Science ®Google Scholar
• Shevtsov S, Petrotchenko EV, Pedersen LC, Negishi M. (2003). Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. Environ Health Perspect 111:884–888
   PubMed Web of Science ®Google Scholar
• Stanley EL, Hume R, Coughtrie MW. (2005). Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol 240:32–42
   PubMed Web of Science ®Google Scholar
• Strott CA. (2002). Sulfonation and molecular action. Endocr Rev 23:703–732
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kojima T, Kawamori T, et al. (1993). Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res 53:2775–2779
   PubMed Web of Science ®Google Scholar
• Teubner W, Meinl W, Florian S, et al. (2007). Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404:207–215
   PubMed Web of Science ®Google Scholar
• Thomae BA, Rifki OF, Theobald MA, et al. (2003). Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: Functional genetic polymorphism. J Neurochem 87:809–819
   PubMed Web of Science ®Google Scholar
• Toms LM, Allmyr M, Mueller JF, et al. (2011). Triclosan in individual human milk samples from Australia. Chemosphere 85:1682–1686
   PubMed Web of Science ®Google Scholar
• Ung D, Nagar S. (2009). Trans-resveratrol-mediated inhibition of beta-oestradiol conjugation in MCF-7 cells stably expressing human sulfotransferases SULT1A1 or SULT1E1, and human liver microsomes. Xenobiotica 39:72–79
   PubMed Web of Science ®Google Scholar
• Vietri M, De Santi C, Pietrabissa A, et al. (2000a). Fenamates and the potent inhibition of human liver phenol sulphotransferase. Xenobiotica 30:111–116
   PubMed Web of Science ®Google Scholar
• Vietri M, De Santi C, Pietrabissa A, et al. (2000b). Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs. Eur J Clin Pharmacol 56:81–87
   PubMed Web of Science ®Google Scholar
• Vietri M, Pietrabissa A, Mosca F, et al. (2001). Human adult and foetal liver sulphotransferases: Inhibition by mefenamic acid and salicylic acid. Xenobiotica 31:153–161
   PubMed Web of Science ®Google Scholar
• Vietri M, Pietrabissa A, Spisni R, et al. (2000c). Differential inhibition of hepatic and duodenal sulfation of (−)-salbutamol and minoxidil by mefenamic acid. Eur J Clin Pharmacol 56:477–479
   PubMed Web of Science ®Google Scholar
• Vietri M, Vaglini F, Pietrabissa A, et al. (2002). Sulfation of R(−)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin. Xenobiotica 32:587–594
   PubMed Web of Science ®Google Scholar
• Walle T, Eaton EA, Walle UK. (1995). Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase. Biochem Pharmacol 50:731–734
   PubMed Web of Science ®Google Scholar
• Wang LQ, Falany CN, James MO. (2004). Triclosan as a substrate and inhibitor of 3′-phosphoadenosine 5′-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions. Drug Metab Dispos 32:1162–1169
   PubMed Web of Science ®Google Scholar
• Wang LQ, James MO. (2005). Sulfotransferase 2A1 forms estradiol-17-sulfate and celecoxib switches the dominant product from estradiol-3-sulfate to estradiol-17-sulfate. J Steroid Biochem Mol Biol 96:367–374
   PubMed Web of Science ®Google Scholar
• Wang LQ, James MO. (2006). Inhibition of sulfotransferases by xenobiotics. Curr Drug Metab 7:83–104
   PubMed Web of Science ®Google Scholar
• Wang LQ, Lehmler HJ, Robertson LW, et al. (2005). In vitro inhibition of human hepatic and cDNA-expressed sulfotransferase activity with 3-hydroxybenzo[a]pyrene by polychlorobiphenylols. Environ Health Perspect 113:680–687
   PubMed Web of Science ®Google Scholar
• Wang LQ, Lehmler HJ, Robertson LW, James MO. (2006). Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate. Chem Biol Interact 159:235–246
   PubMed Web of Science ®Google Scholar
• Waring RH, Ayers S, Gescher AJ, et al. (2008). Phytoestrogens and xenoestrogens: The contribution of diet and environment to endocrine disruption. J Steroid Biochem Mol Biol 108:213–220
   PubMed Web of Science ®Google Scholar
• Whittemore RM, Pearce LB, Roth JA. (1985). Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Biochemistry 24:2477–2482
   PubMed Web of Science ®Google Scholar
• Yalcin EB, Struzik SM, King RS. (2008). Allosteric modulation of SULT2A1 by celecoxib and nimesulide: Computational analyses. Drug Metab Lett 2:198–204
   PubMedGoogle Scholar
• Yasuda S, Idell S, Fu J, et al. (2007). Cigarette smoke toxicants as substrates and inhibitors for human cytosolic SULTs. Toxicol Appl Pharmacol 221:13–20
   PubMed Web of Science ®Google Scholar
• Yasuda S, Suiko M, Liu MC. (2005). Oral contraceptives as substrates and inhibitors for human cytosolic SULTs. J Biochem 137:401–406
   PubMed Web of Science ®Google Scholar
• Yeh CT, Yen GC. (2003). Effects of phenolic acids on human phenolsulfotransferases in relation to their antioxidant activity. J Agric Food Chem 51:1474–1479
   PubMed Web of Science ®Google Scholar
• Young WF, Jr Laws ER, Jr Sharbrough FW, Weinshilboum RM. (1985). Human phenol sulfotransferase: Correlation of brain and platelet activities. J Neurochem 44:1131–1137
   PubMed Web of Science ®Google Scholar
• Zhang H, Varlamova O, Vargas FM, et al. (1998). Sulfuryl transfer: The catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 273:10888–10892
   PubMed Web of Science ®Google Scholar